Tag: SQ

Panic Buying/Selling Goes Viral

Co-Diagnostic Inc. CODX – Review

The last time we mentioned CODX in one of our reports was toward the end of last month, and at the time the coronavirus was not inspiring as much fear as it is presently, but the stock had still already begun to trade high volume and edge upward.

Now, with the CDC warning of a potential pandemic, even as some public officials attempt to downplay the significance, fear-buying has driven up stocks like CODX, which happened to be the #2 gainer on the NASDAQ yesterday. It enabled new highs for us, and we’ve now seen CODX run from a low of 1.52 up to 10.89 in just over a month’s time! That’s a fantastic increase of 616%

The stock has broken $14 in the premarket, so our observed range stands to increase significantly today.

Vaxart Inc. VXRT

Speaking of coronavirus plays, we signaled VXRT on January 31st and promptly provided an update this month on the 4th, and it too has enjoyed a fear-powered run up the chart.

Our initially observed low on this play was .956, and as of yesterday’s new high of 1.91 that works out to an upswing of 99% With the stock on the verge of hurtling upward into blue skies, (over $2 in the premarket) we’re going to want to continue to keep an eye peeled for further activity.

Fresh Options Ideas:
SQ Weekly $78-80.50 Calls
MAR Weekly $120-117 Puts 

Extended Watchlist:
PXYN, MRNA, TNXP, INO, LMPX, SIX, 

Blue Horseshoe Stocks: XXII Update & More

22nd Century Group, Inc. XXII

It was back on November 7th that we highlighted a large group of cannabis stocks, and professed our unyielding interest in the space as a whole. XXII was among those that we specifically highlighted as promising pot stocks in that report, and despite it being more than 8 weeks later, the stock has continually bulled its ways to new highs ever since.

We wanted to swing back around this morning to outline the excellent run it has been on since November. Subsequent to our report on the 7th the stock saw an absolute bottom of 2.00 even before beginning its months-long ascent. Yesterday the stock reached yet another new high of 3.85, marking an overall upswing of 93%

Yield10 Bioscience, Inc. YTEN

Following a huge single session run in early December, YTEN was unable to hold onto any of the ground it had gained, and with the ‘help’ of a massive public offering, continued to descend until recently.

This week, the stock has begun to show signs of a bottom bounce, and we’re going to want to add it to the radar on a recovery watch. As you can see form the chart snapshot included below, there is a lot of room for a potential surge, including a gap to fill to the upside.

Extended Watchlist:
NVAX, RKDA, SDRL, CRBP, SQ, CHFS, NBEV, SIEN, CNET

Blue Horseshoe Stocks: Fresh Options Ideas & More

Horizon Pharma plc  HZNP

Good morning traders! We’re back to kick off another trading week, and we’re going to start off by taking a look at an early mover in HZNP. The stock is gapping up moderately on the tail of a mixed-result earnings release, as a well as the announcement of a 5M share repurchase program.

We’re interested in signaling a pair of options contracts in the HZNP chain for observation, should the bullish sentiment we’re seeing here in the premarket boil over into the session.

Our targets are going to start out as the HZNP Weekly $14 and 15 Calls. Key resistance is currently sitting at the 50DMA of 16.15. In the event that HZNP were to test and breach that boundary, we’d look to roll up our strike price to the $16’s.

Yelp, Inc. YELP

YELP was included in our watchlist on Friday, and the stock produced a bullish performance on the day. We observed a 13% rise on the day from a low of 23.66 to a high of 26.75. That’s a respectable single-session move out of a stock in this price range.

Moving forward, we’ll be watching closely for YELP to maintain support above its current 200DMA of 23.55. That will act as our deciding point on the chart. Should the stock hold above that level on any pullbacks, we’ll look for possible swing-trade opportunities in YELP Weekly $24-27 Calls. Failure to hold that price point would signal us to flip to the bullish side and the $27-24 Puts.

Square, Inc. SQ

We also want to put SQ on a bottom-watch this morning after a post-market earnings call on Thursday precipitated quite a bit of fallout during Friday’s session. Despite a boosted outlook for the remainder of 2016 and big-time growth compared to the same quarter last year, SQ was absolutely hammered.

That makes it fair game for a potential rebound in coming sessions, so we’ll have it on our radar for that possibility. If it appears that a recovery is imminent, we’ll look to use in-the-money calls to leverage some nice gains out of this play.

Extended Watchlist:
JNSH, BTSC, TALK, GEVO, SSYS, PTX,